
British Ambassador to Manila Daniel Pruce announced on Friday that the Philippines is expected to receive 10 million doses of COVID-19 vaccine from the COVAX Facility, most of which are manufactured by Oxford-AstraZeneca.
The ambassador claimed that Britain funded about 548 million pounds in the COVAX Advance Market Commitment. This will help in the distribution of vaccines under the alliance to up to 92 developing countries, including the Philippines.
“The Facility expects doses will be available for delivery starting in the first quarter of 2021, perhaps as early as February, that pending the emergency use listing from the WHO (World Health Organization),” Pruce said in a statement.
COVAX is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, and WHO.
It aims to accelerate the manufacture and development of COVID-19 vaccines and to guarantee fair and equitable access across the world, especially for low- and middle-income economies.
“This is part of our commitment to supporting countries around the world to get equitable access to Covid vaccines as part of their response to the coronavirus pandemic,” he said.